EU approves Gilead's HIV drug combo

02/24/2005 | iWon

Gilead Sciences reports it received European Commission approval to market its HIV drug Truvada in the European Union. Truvada combines two HIV drugs, Emtriva and Viread, in one pill, which can be taken once a day along with other antiretroviral medicines.

View Full Article in:

iWon

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Director, Corporate Counsel
Regeneron
Tarrytown, NY